Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease clinical trial (NCT01809262). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Olodaterol compare to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease clinical trial (NCT01809262). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease clinical trial (NCT01809262). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease clinical trial (NCT01809262). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease clinical trial (NCT01809262). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary Disease clinical trial (NCT01809262). Contact the study team or your healthcare provider for specific answers.

What this study is about